Stockscreener 앱 받기
14.54
1.36%
-0.20
시간 외 거래:
14.51
-0.03
-0.21%
전일 마감가:
$14.74
열려 있는:
$14.78
하루 거래량:
3.45M
Relative Volume:
1.09
시가총액:
$3.47B
수익:
$426.45M
순이익/손실:
$197.67M
주가수익비율:
17.73
EPS:
0.82
순현금흐름:
$110.10M
1주 성능:
-0.82%
1개월 성능:
-7.74%
6개월 성능:
-22.16%
1년 성능:
-14.52%
1일 변동 폭
$14.28
$14.78
1주일 범위
$13.82
$14.82
52주 변동 폭
$13.82
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
명칭
Adma Biologics Inc
전화
(201) 478-5552
주소
C/O ADMA BIOLOGICS, INC., RAMSEY
ADMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
14.54 | 3.52B | 426.45M | 197.67M | 110.10M | 0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-19 | 재개 | Raymond James | Strong Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 개시 | Jefferies | Buy |
| 2019-04-15 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-07 | 재개 | H.C. Wainwright | Buy |
| 2017-12-11 | 재확인 | Maxim Group | Buy |
| 2017-11-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | 업그레이드 | Maxim Group | Hold → Buy |
| 2016-08-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2016-07-25 | 재확인 | Maxim Group | Buy |
| 2015-05-13 | 재확인 | Maxim Group | Buy |
| 2014-12-08 | 개시 | Oppenheimer | Outperform |
| 2014-12-01 | 재확인 | Maxim Group | Buy |
모두보기
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
Can momentum traders help lift ADMA Biologics Inc.Trade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com
Adma Biologics (ADMA) Stock Moves -1.36%: What You Should Know - Nasdaq
Using data filters to optimize entry into ADMA Biologics Inc.Weekly Profit Recap & High Win Rate Trade Tips - newser.com
What momentum shifts mean for ADMA Biologics Inc.Weekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
What moving averages say about ADMA Biologics Inc.2025 Retail Activity & Safe Entry Point Alerts - newser.com
Is ADMA Biologics Inc. stock oversold or undervaluedMarket Volume Summary & Fast Exit/Entry Strategy Plans - newser.com
Volume spikes in ADMA Biologics Inc. stock – what they mean2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com
Using flow based indicators on ADMA Biologics Inc.Trade Volume Report & Weekly High Potential Stock Alerts - newser.com
Weiss Ratings Reaffirms Buy (B-) Rating for ADMA Biologics (NASDAQ:ADMA) - MarketBeat
Can ADMA Biologics Inc. stock beat market expectations this quarter2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com
Should you wait for a breakout in ADMA Biologics Inc.Rate Hike & Verified Chart Pattern Signals - newser.com
What MACD and RSI say about ADMA Biologics Inc.2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com
Is ADMA Biologics Inc. stock trading near support levels2025 Big Picture & Real-Time Stock Entry Alerts - newser.com
Tick level data insight on ADMA Biologics Inc. volatilityJuly 2025 Outlook & Consistent Profit Alerts - newser.com
1,800,440 Shares in ADMA Biologics Inc $ADMA Bought by Vaughan Nelson Investment Management L.P. - MarketBeat
Evaluating ADMA Biologics Inc. with trendline analysisQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - sharewise.com
What analysts say about ADMA Biologics Inc stockRisk Mitigation Techniques & Analyze Your Portfolio Risk in Seconds - earlytimes.in
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 5.1%Here's Why - MarketBeat
ADMA Biologics Inc (ADMA) Stock Analysis: A Promising 86.16% Upside in the Biotech Sector - DirectorsTalk Interviews
ADMA Biologics Inc (ADMA) Stock Analysis: Exploring An 86.16% Potential Upside - DirectorsTalk Interviews
Assenagon Asset Management S.A. Sells 387,872 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Sold by Ausbil Investment Management Ltd - MarketBeat
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? - sharewise.com
Sheets Smith Wealth Management Takes $349,000 Position in ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors - sharewise.com
Exploring High Growth Tech Stocks in the US Market - Yahoo Finance
Are Options Traders Betting on a Big Move in ADMA Biologics Stock? - sharewise.com
Perpetual Ltd Trims Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics Inc (ADMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adma Biologics Inc 주식 (ADMA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Grossman Adam S | President and CEO |
Sep 15 '25 |
Sale |
16.13 |
21,000 |
338,730 |
2,025,850 |
| Grossman Adam S | President and CEO |
Aug 15 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,052,850 |
| Grossman Adam S | President and CEO |
Aug 15 '25 |
Sale |
16.88 |
21,000 |
354,480 |
2,031,850 |
| Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance |
Jul 30 '25 |
Option Exercise |
8.98 |
2,500 |
22,450 |
489,898 |
| Grossman Adam S | President and CEO |
Jul 15 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,058,850 |
| Grossman Adam S | President and CEO |
Jul 15 '25 |
Sale |
18.66 |
21,000 |
391,860 |
2,037,850 |
5.74%
자본화:
|
볼륨(24시간):